BioLineRx (BLRX) director details extensive stock option grants

robot
Abstract generation in progress

BioLineRx Ltd. director Sandra Panem filed an initial ownership report, Form 3, detailing a significant number of employee stock options to purchase ordinary shares. These options include various blocks with different exercise prices and expiration dates ranging from 2026 to 2034. Footnotes indicate that older grants through 2024 are fully vested, while a substantial portion of a more recent October 2024 grant will vest quarterly, conditional on continued service.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin